Clinical Trial Update: Efficacy and Tolerability of Tasipimidine in Sleepless Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tasipimidine for insomnia has completed, reporting on efficacy and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Tasipimidine (Tasipimidine)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Insomnia | Phase 2 | Status: COMPLETED